Market Introduction
Major countries included as a part of analysis for South America includes Argentina, Brazil, and Rest of SAM. The growth of the market for the Genome Editing in the region is attributed to the aging population, flourishing diagnostics market and growing initiatives of the major players in the medical device industry. Furthermore, the prevalence of chronic diseases that demands for promising diagnostic test options is one of the factors that contributes to the growth of the market in the region.
The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the emerging new variants of the COVID19 virus. Amongst which Brazil has registered the majority of the deaths. It is anticipated that the region will likely force a restriction of the international travelers, which will ultimately affect the healthcare industry in the area.
Market Overview and Dynamics
The genome editing market in South America is expected to grow US$ 319.10 million in 2021 to US$ 1,003.03 million by 2028; it is estimated to grow at a CAGR of 17.8% from 2021 to 2028. Growing developments in the healthcare industry have led to increasing applications of biotechnology. Also, the growing support from governments, rising public-private partnerships, and increasing funding are widely enhancing the growth of the biotechnologies industry in the region. The value of the biotechnology industry is growing rapidly in the region due to the growing demand for biotechnology products to address changing diseases profile. In addition, the countries in the emerging regions serve vital growth opportunities due to the ever-increasing population and geriatric population. The heavy investments for the development of the healthcare sector have encouraged the adoption of advanced technologies. Moreover, the governments in the region offer tax incentives, cheaper land, incubators, and direct investment that have encouraged the local biotechnology companies to expand their abilities and capacities to contribute to improved healthcare services. This is expected to increase the demand for genome editing and accelerate the market's growth in the coming years.
Key Market Segments
In term of technological, CRISPR segment held a larger market share of the genome editing market in 2021. In term of application, genetic engineering segment held a larger market share of the genome editing market in 2021. In term of end user, pharmaceutical and biotechnology companies segment held a larger market share of the genome editing market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the genome editing market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; Lonza; Horizon Discovery Group plc.; GenScript; New England Biolabs; Eurofins Scientific; and CRISPR Therapeutics among others.
Reasons to buy report
South America Genome Editing Market Segmentation
South America Genome Editing Market – By Technology
South America Genome Editing Market – By Application
South America Genome Editing Market – By End User
South America Genome Editing Market – By Country
South America Genome Editing Market – Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 319.10 Million |
| Market Size by 2028 | US$ 1,003.03 Million |
| CAGR (2021 - 2028) | 17.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South America Genome Editing Market is valued at US$ 319.10 Million in 2021, it is projected to reach US$ 1,003.03 Million by 2028.
As per our report South America Genome Editing Market, the market size is valued at US$ 319.10 Million in 2021, projecting it to reach US$ 1,003.03 Million by 2028. This translates to a CAGR of approximately 17.8% during the forecast period.
The South America Genome Editing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Genome Editing Market report:
The South America Genome Editing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Genome Editing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Genome Editing Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Genome Editing Market
